LIMA, Peru–(BUSINESS WIRE)–Johnson & Johnson announced the arrival in Peru of a new pulsed field ablation (PFA) technology for the treatment of drug-refractory paroxysmal atrial fibrillation. This incorporation represents a significant advance in the approach to cardiac arrhythmias, with benefits in terms of safety, precision, and procedural efficiency.1 “With this launch, Peru joins the Latin American countries that already have this world-class innovation, used in international referenc